News & Alerts
-
Feb- 2024 -5 February
Novartis in Advanced Talks to Acquire MorphoSys: A Potential Game-Changer in Cancer Treatment
In a significant development, pharmaceutical giant Novartis AG is reportedly in advanced talks to acquire MorphoSys AG, a prominent developer…
Read More » -
2 February
FDA Warns Consumers of Contaminated Copycat Eye Drops: Urges Caution and Vigilance
In a public announcement on January 31, 2024, the U.S. Food and Drug Administration (FDA) issued a stern warning to…
Read More » -
Jan- 2024 -31 January
Global Biosurfactants Market Set to Hit $3.2 Billion By 2032 at 5.4% CAGR
Allied Market Research’s latest report indicates a promising future for the global biosurfactants market, citing stringent regulations on synthetic detergents…
Read More » -
31 January
Novo Nordisk Set to More Than Double U.S. Supply of Lower Wegovy Doses
Novo Nordisk, the Danish pharmaceutical company, is set to significantly increase the supply of lower doses of its obesity drug…
Read More » -
30 January
WHO Blames Rise in Reports of Fake Weight-Loss Drugs To Shortage of The Real Thing
In a recent statement, the World Health Organization (WHO) raised alarm about a surge in reports of counterfeit weight-loss drugs…
Read More » -
29 January
First Patient Enrolled in Rise Therapeutics’ Rheumatoid Arthritis Clinical Trial
In a groundbreaking development, Rise Therapeutics, a pioneering clinical-stage biotechnology company, has enrolled its first patient in the Phase 1…
Read More » -
22 January
FDA Adds Boxed Warning for Prolia in Advanced CKD Due to Severe Risk Of Hypocalcemia
The U.S. Food and Drug Administration (FDA) has issued a Drug Safety Communication regarding Prolia (denosumab), an osteoporosis medication. Following…
Read More » -
19 January
Global 3D Cell Culture Market Projected to Grow at 15% CAGR by 2028
The global 3D cell culture market is set for substantial growth, reaching US$ 2.01 Billion in 2022 and forecasted to…
Read More » -
18 January
FDA Shocker: Shin Nippon’s Migraine Drug Rejected Over Manufacturing Fears, Stock Plummets 12%
In a recent development, the U.S. Food and Drug Administration (FDA) has declined to approve Shin Nippon Biomedical Laboratories’ treatment…
Read More » -
17 January
Sustainable Weight Loss with GLP-1’s and bistroMD
In recent news, bistroMD, a nationally recognized meal delivery service, is addressing the need for sustainable weight loss in conjunction…
Read More »
